NGNE
#2634
Neurogene Inc. - Common Stock
37.8 7 USD
+0.04%
Market Price
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
+4.50%
Variación mensual
+12.98%
Variación en los últimos 6 meses
+88.50%
Cambio anual
+28.72%
Cierres anteriores
36.2 4
Open
37.8 7
Mínimo
37.8 7
Máximo
37.8 7
Volumen
29
Financials
- Market Capitalization 757.83 M
- Employee 131
- Founded 2018
- CEO Jonathan Drachman M.D.
- Website www.neurogene.com
- Headquarter New York, United States
- FIGI BBG005Y0QDK1
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-6.25
Relación precio/flujo de caja
2 346.93
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 2624 |  AURA Aura Biosciences, Inc. - Common Stock | 7.43 USD | +3.48% | -4.25% | +5.99% | +17.94% | 770.53 M USD | ||
| 2632 |  PHAT Phathom Pharmaceuticals, Inc. - Common Stock | 9.39 USD | -1.88% | +6.95% | +7.31% | -20.36% | 759.66 M USD | ||
| 2639 |  NVCT Nuvectis Pharma, Inc. - Common Stock | 23.06 USD | +1.45% | -10.62% | +6.91% | +261.44% | 751.33 M USD | ||
| 2668 |  GYRE Gyre Therapeutics, Inc. - Common Stock | 6.47 USD | -1.52% | -3.58% | +11.55% | -21.67% | 721.47 M USD |